ℹ️
🇬🇧
Search
Search for people relevant for "makroskopické"
makroskopické
Person
Class
Person
Publication
Programmes
Mgr. Lucie Nekvindová Ph.D.
External person at First Faculty of Medicine
22 publications
Publications
publication
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries
2023 |
First Faculty of Medicine
publication
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
2023 |
First Faculty of Medicine
publication
Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA
2022 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Self-perceived general health at start of TNFi therapy predicts therapeutic response in patients with rheumatoid arthritis: analysis from the ATTRA registry
2022 |
Central Library of Charles University, First Faculty of Medicine
publication
Achieving the goal of rheumatoid arthritis treatment is more common in patients with moderate activity than high disease activity in the real clinical practice of the ATTRA National Registry of Biological Treatment
2022 |
Central Library of Charles University, First Faculty of Medicine
publication
Real-world Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients with Psoriatic Arthritis in Thirteen European Countries
2022 |
First Faculty of Medicine
publication
The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry
2022 |
First Faculty of Medicine
publication
Dlouhodobé výsledky léčby baricitinibem v českém národním registru ATTRA
2022 |
First Faculty of Medicine
publication
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
2022 |
First Faculty of Medicine
publication
Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry
2021 |
Central Library of Charles University, First Faculty of Medicine
Load more publications (12)
Loading network view...